Nanalysis Scientific Corp.
NSCIF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $1 | $4 | $10 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $11 | $10 | $7 | $6 |
| Inventory | $4 | $6 | $7 | $4 |
| Other Curr. Assets | $1 | $2 | $4 | $2 |
| Total Curr. Assets | $18 | $18 | $22 | $21 |
| Property Plant & Equip (Net) | $3 | $5 | $6 | $3 |
| Goodwill | $6 | $6 | $13 | $0 |
| Intangibles | $13 | $3 | $27 | $14 |
| Long-Term Investments | $0 | $6 | $1 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $16 | $1 | $0 |
| Total NC Assets | $24 | $36 | $48 | $17 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $42 | $54 | $70 | $38 |
| Liabilities | – | – | – | – |
| Payables | $6 | $5 | $6 | $4 |
| Short-Term Debt | $7 | $7 | $4 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $0 | $2 | $2 |
| Other Curr. Liab. | $1 | $2 | $1 | $0 |
| Total Curr. Liab. | $14 | $15 | $14 | $9 |
| LT Debt | $12 | $15 | $6 | $4 |
| Deferred Rev, NC | $1 | $0 | $1 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $1 | $2 | $1 |
| Total NC Liab. | $12 | $16 | $9 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $3 | $3 | $1 |
| Total Liabilities | $27 | $30 | $22 | $14 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $58 | $53 | $49 | $31 |
| Retained Earnings | -$49 | -$35 | -$19 | -$10 |
| AOCI | $0 | $1 | $1 | $1 |
| Other Equity | $6 | $5 | $4 | $2 |
| Total Equity | $16 | $23 | $35 | $24 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $12 | $0 |
| Total Liab. & Tot. Equity | $42 | $54 | $70 | $38 |
| Net Debt | $17 | $21 | $7 | -$4 |